# Pixelworks, Inc: financial statements, quarterly

PXLW · Nasdaq · CIK 1040161 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pxlw.md) · [Financials](/companies/pxlw/financials.md) · [Filings](/companies/pxlw/filings.md) · [Insiders](/companies/pxlw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pxlw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [16.0](/filings/0001040161-24-000042.md) | [20.1 d](/filings/0001040161-25-000010.md) | [16.1](/filings/0001040161-25-000027.md) | [8.5](/filings/0001040161-25-000043.md) | [9.5](/filings/0001040161-25-000053.md) | [9.1 d](/filings/0001040161-25-000010.md) | [7.1](/filings/0001040161-25-000027.md) | [8.3](/filings/0001040161-25-000043.md) | [8.8](/filings/0001040161-25-000053.md) | [(23.4) d](/filings/0001040161-26-000019.md) | [0.4](/filings/0001040161-26-000032.md) | [0.1](/filings/0001040161-26-000043.md) |
| Cost of revenue | $m | [9.2](/filings/0001040161-24-000042.md) | [11.1 d](/filings/0001040161-25-000010.md) | [7.9](/filings/0001040161-25-000027.md) | [4.2](/filings/0001040161-25-000043.md) | [4.6](/filings/0001040161-25-000053.md) | [(16.7) d](/filings/0001040161-26-000019.md) | [0.0](/filings/0001040161-26-000032.md) | [0.0](/filings/0001040161-26-000043.md) | [4.4](/filings/0001040161-25-000053.md) | [(12.4) d](/filings/0001040161-26-000019.md) | [0.2](/filings/0001040161-26-000032.md) | [0.0](/filings/0001040161-26-000043.md) |
| Gross profit | $m | [6.9](/filings/0001040161-24-000042.md) | [9.0 d](/filings/0001040161-25-000010.md) | [8.1](/filings/0001040161-25-000027.md) | [4.3](/filings/0001040161-25-000043.md) | [4.9](/filings/0001040161-25-000053.md) | [(16.8) d](/filings/0001040161-26-000019.md) | [(0.0)](/filings/0001040161-26-000032.md) | [0.1](/filings/0001040161-26-000043.md) | [4.4](/filings/0001040161-25-000053.md) | [(11.0) d](/filings/0001040161-26-000019.md) | [0.3](/filings/0001040161-26-000032.md) | [0.0](/filings/0001040161-26-000043.md) |
| Research and development | $m | [8.8](/filings/0001040161-24-000042.md) | [7.0 d](/filings/0001040161-25-000010.md) | [8.1](/filings/0001040161-25-000027.md) | [7.9](/filings/0001040161-25-000043.md) | [8.4](/filings/0001040161-25-000053.md) | [(20.0) d](/filings/0001040161-26-000019.md) | [1.0](/filings/0001040161-26-000032.md) | [0.9](/filings/0001040161-26-000043.md) | [5.7](/filings/0001040161-25-000053.md) | [(14.5) d](/filings/0001040161-26-000019.md) | [1.0](/filings/0001040161-26-000032.md) | [1.2](/filings/0001040161-26-000043.md) |
| Selling, general and administrative | $m | [5.8](/filings/0001040161-24-000042.md) | [6.2 d](/filings/0001040161-25-000010.md) | [5.5](/filings/0001040161-25-000027.md) | [5.7](/filings/0001040161-25-000043.md) | [5.0](/filings/0001040161-25-000053.md) | [(7.4) d](/filings/0001040161-26-000019.md) | [2.1](/filings/0001040161-26-000032.md) | [1.7](/filings/0001040161-26-000043.md) | [4.3](/filings/0001040161-25-000053.md) | [(4.9) d](/filings/0001040161-26-000019.md) | [2.2](/filings/0001040161-26-000032.md) | [2.1](/filings/0001040161-26-000043.md) |
| Operating income | $m | [(7.6)](/filings/0001040161-24-000042.md) | [(4.1) d](/filings/0001040161-25-000010.md) | [(5.5)](/filings/0001040161-25-000027.md) | [(10.7)](/filings/0001040161-25-000043.md) | [(8.6)](/filings/0001040161-25-000053.md) | [11.9 d](/filings/0001040161-26-000019.md) | [(3.1)](/filings/0001040161-26-000032.md) | [(2.5)](/filings/0001040161-26-000043.md) | [(5.6)](/filings/0001040161-25-000053.md) | [9.5 d](/filings/0001040161-26-000019.md) | [(4.9)](/filings/0001040161-26-000032.md) | [(3.4)](/filings/0001040161-26-000043.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2](/filings/0001040161-24-000042.md) | [0.0 d](/filings/0001040161-25-000010.md) | [0.1](/filings/0001040161-25-000027.md) | [0.0](/filings/0001040161-25-000043.md) | [0.1](/filings/0001040161-25-000053.md) | [(0.2) d](/filings/0001040161-26-000019.md) | [(0.2)](/filings/0001040161-26-000032.md) | [0.1](/filings/0001040161-26-000043.md) | [(0.5)](/filings/0001040161-25-000053.md) | [(0.2) d](/filings/0001040161-26-000019.md) | [(0.0)](/filings/0001040161-26-000032.md) | [0.0](/filings/0001040161-26-000043.md) |
| Net income | $m | [(7.0)](/filings/0001040161-24-000042.md) | [(3.7) d](/filings/0001040161-25-000010.md) | [(5.1)](/filings/0001040161-25-000053.md) | [(10.1)](/filings/0001040161-25-000053.md) | [(8.1)](/filings/0001040161-25-000053.md) | [(5.4) d](/filings/0001040161-26-000019.md) | [(7.8)](/filings/0001040161-26-000043.md) | [(6.7)](/filings/0001040161-26-000043.md) | [(4.4)](/filings/0001040161-25-000053.md) | [(3.6) d](/filings/0001040161-26-000019.md) | [80.6](/filings/0001040161-26-000043.md) | [(2.8)](/filings/0001040161-26-000043.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0001040161-24-000042.md) | not reported | [(0.09)](/filings/0001040161-25-000027.md) | [(2.09)](/filings/0001040161-25-000043.md) | [(1.66)](/filings/0001040161-25-000053.md) | not reported | [(1.54)](/filings/0001040161-26-000032.md) | [(1.27)](/filings/0001040161-26-000043.md) | [(0.81)](/filings/0001040161-25-000053.md) | not reported | [12.46](/filings/0001040161-26-000032.md) | [(0.44)](/filings/0001040161-26-000043.md) |
| Basic EPS | $ per share | [(0.12)](/filings/0001040161-24-000042.md) | not reported | [(0.09)](/filings/0001040161-25-000027.md) | [(2.09)](/filings/0001040161-25-000043.md) | [(1.66)](/filings/0001040161-25-000053.md) | not reported | [(1.54)](/filings/0001040161-26-000032.md) | [(1.27)](/filings/0001040161-26-000043.md) | [(0.81)](/filings/0001040161-25-000053.md) | not reported | [12.69](/filings/0001040161-26-000032.md) | [(0.44)](/filings/0001040161-26-000043.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [50.3](/filings/0001040161-23-000050.md) | [47.5](/filings/0001040161-25-000010.md) | [46.2](/filings/0001040161-24-000018.md) | [37.8](/filings/0001040161-24-000031.md) | [28.8](/filings/0001040161-24-000042.md) | [5.5](/filings/0001040161-26-000019.md) | [18.5](/filings/0001040161-25-000027.md) | [14.3](/filings/0001040161-25-000043.md) | [14.6](/filings/0001040161-25-000053.md) | [11.2](/filings/0001040161-26-000043.md) | [57.8](/filings/0001040161-26-000032.md) | [52.9](/filings/0001040161-26-000043.md) |
| Current assets | $m | [68.7](/filings/0001040161-23-000050.md) | [64.7](/filings/0001040161-25-000010.md) | [59.0](/filings/0001040161-24-000018.md) | [50.0](/filings/0001040161-24-000031.md) | [39.7](/filings/0001040161-24-000042.md) | [34.9](/filings/0001040161-26-000019.md) | [30.6](/filings/0001040161-25-000027.md) | [25.6](/filings/0001040161-25-000043.md) | [25.3](/filings/0001040161-25-000053.md) | [50.2](/filings/0001040161-26-000043.md) | [59.2](/filings/0001040161-26-000032.md) | [53.4](/filings/0001040161-26-000043.md) |
| Total assets | $m | [101](/filings/0001040161-23-000050.md) | [96.0](/filings/0001040161-25-000010.md) | [91.8](/filings/0001040161-24-000018.md) | [81.6](/filings/0001040161-24-000031.md) | [71.1](/filings/0001040161-24-000042.md) | [64.1](/filings/0001040161-26-000019.md) | [58.5](/filings/0001040161-25-000027.md) | [51.8](/filings/0001040161-25-000043.md) | [50.5](/filings/0001040161-25-000053.md) | [51.3](/filings/0001040161-26-000043.md) | [60.0](/filings/0001040161-26-000032.md) | [54.1](/filings/0001040161-26-000043.md) |
| Current liabilities | $m | [14.7](/filings/0001040161-23-000050.md) | [12.3](/filings/0001040161-25-000010.md) | [12.4](/filings/0001040161-24-000018.md) | [11.9](/filings/0001040161-24-000031.md) | [9.9](/filings/0001040161-24-000042.md) | [8.3](/filings/0001040161-26-000019.md) | [8.8](/filings/0001040161-25-000027.md) | [9.1](/filings/0001040161-25-000043.md) | [9.8](/filings/0001040161-25-000053.md) | [20.0](/filings/0001040161-26-000043.md) | [2.1](/filings/0001040161-26-000032.md) | [1.5](/filings/0001040161-26-000043.md) |
| Total liabilities | $m | [33.6](/filings/0001040161-23-000050.md) | [31.0](/filings/0001040161-25-000010.md) | [30.8](/filings/0001040161-24-000018.md) | [30.1](/filings/0001040161-24-000031.md) | [27.0](/filings/0001040161-24-000042.md) | [24.2](/filings/0001040161-26-000019.md) | [24.0](/filings/0001040161-25-000027.md) | [23.5](/filings/0001040161-25-000043.md) | [23.6](/filings/0001040161-25-000053.md) | [20.9](/filings/0001040161-26-000043.md) | [2.8](/filings/0001040161-26-000032.md) | [2.1](/filings/0001040161-26-000043.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [16.2](/filings/0001040161-23-000050.md) | [12.5](/filings/0001040161-25-000010.md) | [9.5](/filings/0001040161-24-000018.md) | [0.5](/filings/0001040161-24-000031.md) | [(8.0)](/filings/0001040161-24-000042.md) | [(10.6)](/filings/0001040161-26-000019.md) | [(16.0)](/filings/0001040161-25-000027.md) | [(22.4)](/filings/0001040161-25-000043.md) | [(23.9)](/filings/0001040161-25-000053.md) | [(21.1)](/filings/0001040161-26-000043.md) | [57.2](/filings/0001040161-26-000032.md) | [52.0](/filings/0001040161-26-000043.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,180) d](/filings/0001040161-24-000042.md) | [(1,788) d](/filings/0001040161-25-000010.md) | [(815)](/filings/0001040161-25-000027.md) | [(5,577) d](/filings/0001040161-25-000043.md) | [(7,814) d](/filings/0001040161-25-000053.md) | [(5,601) d](/filings/0001040161-26-000019.md) | [(6,716)](/filings/0001040161-26-000032.md) | [(4,552) d](/filings/0001040161-26-000043.md) | [(2,860) d](/filings/0001040161-25-000053.md) | [(6,478) d](/filings/0001040161-26-000019.md) | [(4,583)](/filings/0001040161-26-000032.md) | [(1,712) d](/filings/0001040161-26-000043.md) |
| Capital expenditure | $k | [736 d](/filings/0001040161-24-000042.md) | [392 d](/filings/0001040161-25-000010.md) | [386](/filings/0001040161-25-000027.md) | [2,480 d](/filings/0001040161-25-000043.md) | [781 d](/filings/0001040161-25-000053.md) | [113 d](/filings/0001040161-26-000019.md) | [17.0](/filings/0001040161-26-000032.md) | [223 d](/filings/0001040161-26-000043.md) | [163 d](/filings/0001040161-25-000053.md) | [45.0 d](/filings/0001040161-26-000019.md) | [105](/filings/0001040161-26-000032.md) | [29.0 d](/filings/0001040161-26-000043.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [54.8](/filings/0001040161-23-000050.md) | [55.7](/filings/0001040161-24-000018.md) | [55.9](/filings/0001040161-24-000031.md) | [56.4](/filings/0001040161-24-000042.md) | [57.5](/filings/0001040161-25-000027.md) | [4.8](/filings/0001040161-25-000043.md) | [4.9](/filings/0001040161-25-000053.md) | [5.0](/filings/0001040161-26-000032.md) | [5.3](/filings/0001040161-26-000043.md) | [5.4](/filings/0001040161-25-000053.md) | [6.5](/filings/0001040161-26-000032.md) | [6.3](/filings/0001040161-26-000043.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,049,393 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001040161-26-000043.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.